2026 NPPES data Otolaryngology Physician NPI 1821260084 M.D.
Verify on CMS →

MATTHEW RUSSELL, M.D.

Otolaryngology Physician in STONEHAM, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
418
Medicare Part D claims · 187 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$124.45
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MATTHEW RUSSELL, M.D. filed 418 Medicare Part D claims in 2023 as a Otolaryngology Physician in STONEHAM, Massachusetts, prescribing 96% generic.

418
Part D claims, 2023
96%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MATTHEW RUSSELL, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

418 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MATTHEW RUSSELL, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MATTHEW RUSSELL, M.D.?

Quality data not reported

NPI registry status

Active

Issued 03/28/2008

NPI 1821260084

Primary specialty

Otolaryngology Physician

Mid-sized

10,895 US NPIs in this specialty

Medicare Part D claims

418 18% vs specialty avg

2023 prescription claims

Specialty avg: 509

Specialty distribution in Massachusetts

How Otolaryngology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Otolaryngology Physician share within Massachusetts

1. Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Otolaryngology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Otolaryngology Physician ABMS/AOA estimate

Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Otolaryngology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATTHEW RUSSELL, M.D. is a Otolaryngology Physician provider practicing in STONEHAM, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1821260084. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MATTHEW RUSSELL, M.D. appears in the CMS NPPES registry as a Otolaryngology Physician provider holding M.D. credentials at 41 MONTVALE AVE STE 200, STONEHAM, MA, 02180, with a listed phone of (781) 279-0971. NPI 1821260084 was issued on 03/28/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RUSSELL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 418 prescription claims written by this provider, covering 187 Medicare beneficiaries and totaling roughly $13K in drug spend, split 4% brand-name and 96% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

41 MONTVALE AVE STE 200
STONEHAM, MA 02180

Provider Details

NPI 1821260084
Specialty Otolaryngology Physician
Credentials M.D.
Gender Male
NPI Issued 03/28/2008

Hospital and facility affiliations

Facilities where MATTHEW RUSSELL, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MASSACHUSETTS EYE AND EAR ASSOCIATES, INC
STONEHAM, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW RUSSELL, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$124

Largest payer

Regeneron Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MATTHEW RUSSELL, M.D.. To verify MATTHEW RUSSELL, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MATTHEW RUSSELL, M.D. — brand share 4.0%
Specialty average (est.)

4% brand-name claims vs 96% generic, on 418 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

418
Total Claims
$13K
Total Drug Cost
187
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
647
Total Day Supply
16,594
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$3K
Generic Drug Cost
$9K
Antibiotic Claims
25

Patient Demographics

Average Patient Age
72.4 years
Avg HCC Risk Score
1.14
Gender Split
63% female / 37% male
Age Distribution
<65: 21, 65-74: 89, 75-84: 56, 85+: 21

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Fluticasone Propionate
97
Omeprazole
87
Ipratropium Bromide
32
Fluocinolone Acetonide Oil
31
Azelastine Hcl
23
Prednisone
13
Ibuprofen
11
Mupirocin
11
Neomycin-Polymyxin-Hc
Neomycin/Polymyxin B/Hydrocort
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology Physician Overview

How MATTHEW RUSSELL, M.D. fits within the Otolaryngology Physician landscape nationally.

10,895
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider

MATTHEW RUSSELL, M.D.'s 418 claims are below the specialty average of 509.

Nearby Otolaryngology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as RUSSELL.

Compare Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATTHEW RUSSELL, M.D.'s specialty?
MATTHEW RUSSELL, M.D. specializes in Otolaryngology Physician and practices in STONEHAM, Massachusetts. Credentials: M.D..
How much does MATTHEW RUSSELL, M.D. prescribe under Medicare Part D?
In 2023, MATTHEW RUSSELL, M.D. wrote 418 Medicare Part D claims totaling $13K in drug costs for 187 beneficiaries.
Where is MATTHEW RUSSELL, M.D. located?
MATTHEW RUSSELL, M.D. is located at 41 MONTVALE AVE STE 200, STONEHAM, MA, 02180. Phone: (781) 279-0971.
What is MATTHEW RUSSELL, M.D.'s NPI number?
MATTHEW RUSSELL, M.D.'s National Provider Identifier (NPI) is 1821260084, issued on 03/28/2008.
Does MATTHEW RUSSELL, M.D. prescribe more brand-name or generic drugs?
MATTHEW RUSSELL, M.D.'s prescribing is 4% brand-name and 96% generic drugs by claim count, with $3K in brand drug costs.
How many Otolaryngology Physician providers are there in the US?
There are 10,895 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does MATTHEW RUSSELL, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MATTHEW RUSSELL, M.D.'s most frequently prescribed drugs include Fluticasone Propionate, Omeprazole, Ipratropium Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATTHEW RUSSELL, M.D. accept Medicare?
MATTHEW RUSSELL, M.D. appears in CMS Medicare data with 418 Part D claims and 187 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATTHEW RUSSELL, M.D.'s credentials?
MATTHEW RUSSELL, M.D.'s NPI is 1821260084 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology